← FDA Drug Approvals (Drugs@FDA)

ACYCLOVIR

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2022-08-18

Drug application

FDA Application #
ANDA215724
Application type
Abbreviated New Drug Application (Generic)
Brand name
ACYCLOVIR
Generic name
ACYCLOVIR
Active ingredients
ACYCLOVIR
Dosage form
SUSPENSION
Route
ORAL
Marketing status
Prescription
Sponsor
RUBICON RESEARCH
Manufacturer
Advagen Pharma Limited
First approval
2022-08-18

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown